Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Mairs & Power - Balanced Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
YTD+6.61%
Annualized+0.0932%
Positioning StanceCAUTIOUS
Market CapAll Cap
Digest Analysis
Quick Take
"The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising fixed-income credit quality ahead of rate easing in 2026."
Executive Summary
The Mairs & Power Balanced Fund finished 2025 up 6.61%, underperforming its composite benchmark (13.52%) and Morningstar peers due to equity underperformance, specifically a relative underweight to high-performing AI technology leaders and adverse stock selection in IT, Financials, and Healthcare. In contrast, the fund's fixed income portfolio outperformed its benchmark through active credit selection and a focus on shorter maturities. During the year, the fund initiated positions in Amazon, WEC Energy, and Travelers, while exiting Honeywell, Principal Financial Group, Neogen, and Target. The manager views the current market as entering a higher-risk transition phase for AI, but expects lower interest rates to gradually support small businesses and consumer spending in 2026.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
80%
Market Conviction
High-conviction positioning: The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising f...
75%
Growth Outlook
Market outlook remains moderate conviction: The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising f...
70%
Risk Appetite
Risk appetite posture is moderate conviction: The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising f...
50%
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising f...
75%
Forward Guidance
Forward guidance signal: The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising f...
80%
Language Signal
Tone analysis indicates above average conviction language: The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising f...
70%
Perceived Risk
Perceived risk level is evaluated as above average conviction. The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising f...
50%
Opportunity Density
Opportunity density index indicates moderate conviction actionable entry points. The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising f...
90%
Time Horizon
Investment time horizon reflects a high conviction orientation. The fund finished 2025 up 6.61%, lagging benchmarks due to underweight tech-leader allocations and adverse stock selection, but remains focused on quality compounders and raising f...